Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans

Journal of Infectious Diseases

Volumn 209, Issue 3, 2014, Pages 355-359

  Wojcik, Genevieve ^a   Latanich, Rachel ^b   Mosbruger, Tim ^b   Astemborski, Jacquie ^b   Kirk, Gregory D ^a,b   Mehta, Shruti H ^a   Goedert, James J ^c   Kim, Arthur Y ^d   Seaberg, Eric C ^a   Busch, Michael ^e,f   Thomas, David L ^a,b   Duggal, Priya ^a   Thio, Chloe L ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

hepatitis C virus; human genetics; Tim 1

Indexed keywords

HLA ANTIGEN; INTERLEUKIN 28B; KIDNEY INJURY MOLECULE 1;

AFRICAN AMERICAN; ARTICLE; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOME SIZE; HAPLOTYPE; HAVCR1 GENE; HEPATITIS C; HLA GENE; HUMAN; IL28B GENE; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE;

HEPATITIS C VIRUS; HUMAN GENETICS; TIM 1;

AFRICAN AMERICANS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS C, CHRONIC; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; RECEPTORS, VIRUS;

EID: 84892667055     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit444     Document Type: Article

References (14)

1. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999; 340:1228-33.
2. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284:450-6.
3. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461:798-801.
4. Thio CL, Thomas DL, Goedert JJ, et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis 2001; 184: 16-21.
5. Mosbruger TL, Duggal P, Goedert JJ, et al. Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. J Infect Dis 2010; 201:1371-80.
6. Umetsu SE, Lee WL, McIntire JJ, et al. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 2005; 6:447-54.
7. Duggal P, Thio CL,Wojcik GL, et al. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med 2013; 158:235-45.
8. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5:e1000529.
9. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet 2010; 11:499-511.
10. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007; 39:906-13.
11. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38:e164.
12. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7:248-9.
13. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-89.
14. Abad-Molina C, Garcia-Lozano JR., Montes-Cano MA, et al. HAVCR1 gene haplotypes and infection by different viral hepatitis C virus genotypes. Clin Vaccine Immunol 2012; 19:223-7.